Newsroom

Industry News

25 Aug

Intellipharmaceutics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference

TORONTO, Aug. 25, 2016 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the Company is scheduled to present at the 18th Annual...

Read more

25 Aug

BioLineRx and I-Bridge Capital Establish a New Drug Development Joint Venture in China

TEL AVIV, Israel, August 25, 2016 /PRNewswire/ — BioLineRx Ltd. (NASDAQ/TASE:BLRX), a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing innovative therapies in...

Read more

24 Aug

RegeneRx Joint Venture to Begin Second Phase 3 Study Of RGN-259 for Dry Eye Syndrome in 3rd Quarter

ROCKVILLE, Md., Aug. 24, 2016 /PRNewswire/ — RegeneRx Biopharmaceuticals, Inc. (RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its U.S. joint venture, ReGenTree, LLC, has received permission from the U.S. FDA to proceed with a second Phase 3 clinical trial...

Read more

23 Aug

Grow Solutions Inc. Reports Financial Results for Second Quarter 2016

Sales Increase 25% to $1.7 Million from Previous Quarter NEW YORK, NY / ACCESSWIRE / August 23, 2016 / Grow Solutions Inc. (OTC: GRSO), a provider of comprehensive support services in the broad area of high-yield indoor agriculture, specializing, though not limited to, the regulated growing and processing of cannabis, today...

Read more

23 Aug

Actinium Pharmaceuticals to Present at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference

NEW YORK, NY–(Marketwired – August 23, 2016) –  Company Presentation Scheduled for Friday, September 9, 2016 at 2:30 PM ET Management to Participate in 1-on-1 Investor Meetings Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or the “Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers,...

Read more

22 Aug

Cytori Therapeutics Receives Frost & Sullivan 2016 Technology Innovation Award

SAN DIEGO–(BUSINESS WIRE)– Cytori Therapeutics, Inc. (CYTX) (“Cytori” or the “Company”) today announced that it has received the Frost & Sullivan 2016 Technology Innovation Award in recognition of advancements made in the field of regenerative medicine for over a decade. Frost & Sullivan’s industry research and benchmarking analysis report...

Read more

22 Aug

Moleculin Appoints New Chief Financial Officer

HOUSTON, TX–(Marketwired – August 22, 2016) – Moleculin Biotech, Inc., (MBRX)(“Moleculin” or the “Company”), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer...

Read more

Page 1 of 17612345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address